Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors

Biological Chemistry

Volumn 384, Issue 6, 2003, Pages 883-890

  Katunuma, Nobuhiko ^a   Matsunaga, Yoichi ^b   Himeno, Kunisuke ^c   Hayashi, Yoshio ^d  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Antigen presentation; Antigen processing; Autoantigen; Cathepsin; Cathepsin inhibitor; T cell response

Indexed keywords

ANTIGEN; AUTOANTIGEN; CA 074; CATHEPSIN; CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; CD4 ANTIGEN; CLIK 148; CLIK 195; CLIK 60; CYSTEINE PROTEINASE; ENZYME INHIBITOR; FODRIN; HEPATITIS B VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; OVALBUMIN; PROTEINASE INHIBITOR; PYRIDOXAL 5 PHOSPHATE; RABIES VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME CONFORMATION; HELPER CELL; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; LEISHMANIA MAJOR; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SHORT SURVEY; SJOEGREN SYNDROME; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNE DISEASES; CATHEPSINS; HUMANS;

HEPATITIS B VIRUS; LEISHMANIA MAJOR;

EID: 0037810382     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.099     Document Type: Short Survey

References (30)

1. Allen P.M., Mauteda, R.J., Evans, U.B., Dunbar Jr., J.B., G.R., and Unanue, E.R. (1987). Identification of the T-cell and Ia contact residues of residues of a T-cell antigenic apitope. Nature 327, 713-715.
2. Brown, J.H., Jardetzky, T., Saper, M.A., Samraoui, B., Bjorkman, P.J., and Wiley, D.C. (1988). A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 332, 845-850.
3. Guagliardi, L.E., Koppelman, B., Blum, J.S., Marks, M.S., Cresswell, P., and Brodsky, F.M. (1990). Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343, 133-139.
4. Haneji, H., Nakamura, T., Takio, K., Yanagi, K., Higashiyama, H., Saito, I., Noji, S., Sugino, H., and Hayashi, Y. (1997). Identification of α-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 276, 604-607.
5. 3H]E-64 into rat liver lysosomes in vivo. J. Biochem. (Tokyo) 91, 1373-1380.
6. Katunuma, N., and Kominami, E. (1955). Structure, properties, mechanisms and assays of cysteine protease inhibitors; cystatins and E-64 derivatives. Methods Enzymol. 251, 382-397.
7. Katunuma, N., Matsunaga, Y., and Saibara, T. (1994). Mechanism and regulation of antigen processing by cathepsin B. Adv. Enzyme Regul. 34, 145-158.
8. Katunuma, N., Matsunaga, Y., Matsui. A., Kakegawa, H., Endo, K., Inubushi, T., Saibara, T., Kakiuchi, T. (1998). Novel physiological functions of cathepsin B and L on antigen processing and osteoclastic bone absorption. Adv. Enzyme Regul. 38, 235-251.
9. Katunuma, N., Murata, E., Kakegawa, H., Matsui, A., Tsuzuki, H., Tsuge, H., Turk, D., Turk, V., Fukushima, M., Tada, Y., and Asao, T. (1999). Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo. FEBS Lett. 458, 6-10.
10. Katunuma, N., Matsui, A., Inubushi, T., Murata, E., Kakegawa, H., Ohba, Y., Turk, D., Turk, V., Tada, Y., and Asao, T. (2000). Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro. Biochem. Biophys. Res. Commun. 267, 850-854.
11. Kominami, E., Tsukahara, T., Banco, Y., and Katunuma, H. (1985). Distribution of cathepsins B and H in rat tissues and peripheral blood cells. J. Biochem. (Tokyo) 98, 87-93.
12. + T cell differentiation from Th-2 to Th-1 by treatment with cathepsin B inhibitor in experimental Leishmaniasis. J. Immunol. 161, 2120-2127.
13. Marsh, S.G., and Bodmer, J.G. (1993). HLA class II nucleotide sequences. Immunogenetics 37, 79-94.
14. Matsunaga, Y., Saibara, T., Kido, H., and Katunuma, N. (1993). Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett. 324, 325-330.
15. Mosmann, T.R., and Coffman, R.L. (1989). Th-1 and Th-2 cellx: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
16. Murata, M., Miyashita, S., Yokoo, C., Tamai, M., Hanada, K., Hatayama, K., Towatari, T., Nikawa, T., and Katunuma, N. (1991). Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B in vitro. FEBS Lett. 280, 307-310.
17. Musil, D., Zučić, D., Turk, D., R.A., Mayr, I., Huber, R., Popovič, T., Turk, V., Towatari, T., Katunuma, N., and Bode, W. (1991). The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 10, 2321-2330.
18. Rudensky, A.Y., Preston-Hurlburt, P., al-Ramadi, B.K., Rothbard, J., and Janeway Jr., C.A. (1992). Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359, 429-341.
19. Seagusa, K., Ishimaru, H., Yanagi, K., Arakaki, R., Ogawa, K., Salto, I., Katunuma, N., and Hayashi, Y. (2002). Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 110, 361-369.
20. + T cells. Annu. Rev. Immunol. 12, 635-673.
21. Spies, T., Cerundolo, V., Colonna, M., Cresswell, P., Townsend, A., and DeMars, R. (1992). Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355, 644-646.
22. Srinivasa, M., Marsh, E.W., and Piece, S.K. (1991). Characterization of naturally processed antigen bound to major histocompatobility complex class II molecules. Proc. Natl. Acad. Sci. USA 88, 7928-7932.
23. Towatari, T., Nikava, T., Murata, M., Yokoo, C., Tamai, M., Hanada, K., and Katunuma, N. (1991). Novel epoxysuccinyl peptides: A selective inhibitor of cathepsin B in vivo. FEBS Lett. 280, 311-315.
24. Tsuge, H., Nishimura, Y., Tada, Y., Asao, T., Turk, D., Turk, V., and Katunuma, N. (1999). Inhibition mechanisms of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex. Biochem. Biophys. Res. Commun. 266, 411-416.
25. Turk, D., Podobnik, M., Katunuma, N., Bode, W., Huber, R., and Turk, V. (1995). Crystal structure of cathepsin B inhibited with CA030 at 2.0 Å resolution: a basis for the design of specific epoxysuccinyl inhibitors. Biochemistry 34, 4791-4797.
26. Turk, V., Turk, B., and Turk, D. (2001). Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20, 4629-4633.
27. Watts, C. (2001). Antigen processing in the endocytic compartment. Curr. Opin. Immunol. 13, 26-31.
28. Young, J.A., Wilkinson, D., Bodmer, W.F., and Trowsdale, J. (1987). Sequence and evolution of HLA-DR7 and -DRw53 associated β-chain genes. Proc. Natl. Acad. Sci. USA 84, 4929-4933.
29. Zhang, T., Maekawa, Y., Hanba, J., Dainichi, T., Nashed, B.F., Hisaeda, H., Sakai, T., Asao, T., Himeno, K., Good, R.A., and Katunuma, N. (2000). Lysosomal cathepsin B plays an important role in anatigen processing, while cathepsin D is involved in degradation of the invariant chain in ovalbumin-immunized mice. Immunology 100, 13-20.
30. Zhang, T., Maekawa, Y., Sakai, T., Nakano, Y., Ishii, K., Hisaeda, H., Kominami, E., Katunuma, N., Asdao, T., and Himeno, K. (2001). Splenic cathepsin L is matured from the proform by interferon-γ after immunization with exogenous antigens. Biochem. Biophys. Res. Commun. 283, 499-506.